Search

Search Constraints

You searched for: Author/Creator Shamji, M. H.

Search Results

1. A randomized, double‐blind, placebo‐controlled, dose‐finding trial with Lolium perenne peptide immunotherapy. Issue 4 (22nd December 2017)

2. Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project. Issue 1 (23rd November 2016)

3. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Issue 8 (6th April 2017)

5. Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individuals. Issue 2 (February 2015)

6. Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications. Issue 4 (22nd November 2017)

7. Epitope specificity determines cross‐protection of a SIT‐induced IgG4 antibody. Issue 1 (30th September 2015)

10. Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response in seasonal allergic rhinitis patients. Issue 6 (13th February 2018)